| Influenza |
1 |
1 |
| Child |
0 |
0.88 |
| Vaccines |
0 |
0.68 |
| Otolaryngology |
0 |
0.63 |
| COVID-19 |
0 |
0.51 |
| Biologic Therapy |
0 |
0.5 |
| Patient Safety |
0 |
0.5 |
| Pandemic |
0 |
0.99 |
| Pediatric Respiratory Infections |
0 |
0.43 |
| Respiratory Tract Infections |
0 |
0.36 |
| Pandemic Influenza |
0 |
0.35 |
| Lower Respiratory Tract Infection |
0 |
0.31 |
| Upper Respiratory Tract Infection |
0 |
0.31 |
| Epidemic |
0 |
0.25 |
| Epidemic Influenza |
0 |
0.22 |
| Monoclonal Antibody |
0 |
0.19 |
| Adverse Effects |
0 |
0.13 |
| Airway |
0 |
0.13 |
| Clinical Research |
0 |
0.13 |
| Hospital |
0 |
0.13 |
| Immunization |
0 |
0.13 |
| Influenza Vaccine |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Acute Otitis Media |
0 |
0.06 |
| Bronchiolitis |
0 |
0.06 |
| Croup |
0 |
0.06 |
| Cytokines |
0 |
0.06 |
| Europe |
0 |
0.06 |
| Hand |
0 |
0.06 |
| Immunology |
0 |
0.06 |
| Intensive Care Unit |
0 |
0.06 |
| Newborn |
0 |
0.06 |
| Otitis Media |
0 |
0.06 |
| Respiratory Tract |
0 |
0.06 |
| Seasonal Influenza |
0 |
0.06 |